Piedmont Cancer Institute
In research, Piedmont Cancer Institute stands highest in Medicine (#4,327 of 10,443 worldwide) and Health Sciences (#5,803 of 11,982 worldwide), 2022–2025.
- World rank, 2022–2025
- #12,923 of 28,054 · #12,925 all time
- Rank in United States
- #1,787 of 4,192
- Research works
- 422 ▲ 10% vs 2013–17
- Citations
- 15k 35.2 per fractional work
- Top-10% rate
- 16.4% record average 16.5%
- Open access
- 47% world 28%
What is Piedmont Cancer Institute known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #4,327 of 10,443 | 17.1% | 66 | #5305 | |
| Health SciencesDomain | #5,803 of 11,982 | 17.0% | 68 | #7156 |
Each strip is that field’s whole ranked pool, with the notch where Piedmont Cancer Institute sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 4.2×. Every wedge is a field page.
- Immunology and Microbiology 4.2×
- Medicine 3.6×
- Biochemistry, Genetics and Molecular Biology 2.6×
- Neuroscience 1.0×
- Physics and Astronomy 0.8×
- Mathematics 0.7×
- Health Professions 0.6×
- Veterinary 0.4×
- Economics, Econometrics and Finance 0.4×
- Pharmacology, Toxicology and Pharmaceutics 0.4×
- Computer Science 0.3×
- Nursing 0.3×
- Chemistry 0.2×
- Engineering 0.1×
- Decision Sciences 0.1×
- Psychology 0.1×
- Materials Science 0.1×
- Dentistry 0.1×
- Business, Management and Accounting 0.0×
- Social Sciences 0.0×
- Agricultural and Biological Sciences 0.0×
- Arts and Humanities 0.0×
Which keywords describe research at Piedmont Cancer Institute?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Chemotherapy, Radiotherapy, Prognostic Factors, Tumor Microenvironment, Clinical Trials, Lymphoma and Targeted Therapy.
- Molecular Classification
- Squamous Cell Carcinoma
- Survival Analysis
- Prognosis
- Genomic Profiling
- International Myeloma Working Group
- Survival
- Genetic Mutations
- Clinical Practice Guidelines
- Minimal Residual Disease
- CAR T Cells
- Neoadjuvant Therapy
- Tumor Regression
- Metastasis
- Immune Checkpoint Blockade
- Cancer Immunotherapy
- Lymphoma
- Cancer
- Prognostic Factors
- Chemotherapy
- Immunotherapy
- Radiotherapy
- Tumor Microenvironment
- Clinical Trials
- Targeted Therapy
- Biomarkers
- PD-1 and PD-L1
- Leukemia
- Breast Cancer
- Cancer Therapy
- Chimeric Antigen Receptor
- Staging System
- Proteasome Inhibitors
- Precision Medicine
- Diagnosis Criteria
- Texture Analysis
- Metastatic Breast Cancer
- Cetuximab
- Human Papillomavirus
- Dosimetry
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Immunotherapy12▲ 18×16 topics
- Chemotherapy12▲ 18×19 topics
- Radiotherapy8▲ 20×11 topics
- Prognostic Factors7▲ 18×13 topics
- Tumor Microenvironment7▲ 16×8 topics
- Cancer5▲ 4.2×23 topics
- Clinical Trials5▲ 8.2×8 topics
- Lymphoma5▲ 34×4 topics
- Targeted Therapy5▲ 24×4 topics
- Cancer Immunotherapy5▲ 32×3 topics
- Biomarkers4▲ 6.6×9 topics
- Immune Checkpoint Blockade4▲ 38×1 topic
- PD-1 and PD-L14▲ 38×1 topic
- Metastasis4▲ 12×9 topics
- Leukemia4▲ 47×2 topics
- Tumor Regression4▲ 35×2 topics
- Breast Cancer4▲ 16×9 topics
- Neoadjuvant Therapy4▲ 16×5 topics
- Cancer Therapy4▲ 6.4×15 topics
- CAR T Cells3▲ 49×1 topic
- Chimeric Antigen Receptor3▲ 49×1 topic
- Minimal Residual Disease3▲ 49×2 topics
- Staging System3▲ 53×2 topics
- Clinical Practice Guidelines3▲ 5.7×9 topics
- Proteasome Inhibitors3▲ 44×2 topics
- Genetic Mutations3▲ 6.9×12 topics
- Precision Medicine3▲ 6.4×5 topics
- Survival3▲ 22×3 topics
- Diagnosis Criteria3▲ 80×1 topic
- International Myeloma Working Group3▲ 80×1 topic
- Texture Analysis3▲ 12×3 topics
- Genomic Profiling2▲ 25×2 topics
- Metastatic Breast Cancer2▲ 47×2 topics
- Prognosis2▲ 7.9×4 topics
- Cetuximab2▲ 30×2 topics
- Survival Analysis2▲ 9.1×6 topics
- Human Papillomavirus2▲ 19×2 topics
- Squamous Cell Carcinoma2▲ 28×3 topics
- Dosimetry2▲ 33×2 topics
- Molecular Classification2▲ 15×4 topics
Which research topics does Piedmont Cancer Institute publish most on?
By volume in 2022–2025: Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Multiple Myeloma Research and Treatments and Head and Neck Cancer Studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Immunotherapy and Biomarkers Oncology 4 works
- 2 CAR-T cell therapy research Oncology 3 works
- 3 Multiple Myeloma Research and Treatments Hematology 3 works
- 4 Head and Neck Cancer Studies Otorhinolaryngology 2 works
- 5 Lung Cancer Research Studies Oncology 2 works
- 6 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 2 works
- 7 Advanced Radiotherapy Techniques Radiation 2 works
- 8 Protein Degradation and Inhibitors Molecular Biology 2 works
- 9 Pancreatic and Hepatic Oncology Research Oncology 2 works
- 10 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Piedmont Cancer Institute's research output changed?
Output in 2018–2022 was 10% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Atlanta
- Georgia Institute of Technology
- Emory University
- Georgia State University
- Centers for Disease Control and Prevention
- AID Atlanta
- Morehouse School of Medicine
- Children's Healthcare of Atlanta
- Emory University Hospital
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.